No abstract

Background: Atopic dermatitis is a chronic and residive inflammatory skin disease with mild to severe itching and occurs mostly in infant and children. The cause not certainty known and multifactorial.Objective: This study aims to Know the Characteristics of Atopic Dermatitis in Puskesmas Masaran 1, Sragen Regency.Method: This study is descriptive with a retrospective cross-sectional design. Secondary data retrieved from medical records atopic dermatitis patients at Puskesmas Masaran 1 in the period 1 January-31 December 2019 with a sample 248 people then analyze using a computer program.Result: The most atopic dermatitis sufferers were the adult age group (151 people), female gender (139 people),  not working (96 people), atopic history disease found in 112 patients, site of the most lesions was lower extremities (71 patients), and the choice therapy is polytherapy with three types of drugs in 103 patients. Types of drugs are corticosteroids (224 patients), antihistamines (212 patients), and vitamins/minerals (200 patients).Conclusion: Characteristics of atopic dermatitis in Puskesmas Masaran 1 are the most age group is adults, gender is female, types of work is not working, atopic history is atopic dermatitis, and therapeutic options are corticosteroids, antihistamines, and vitamins/minerals.

Introduction : Melasma is one of the most common hyperpigmentation disorders among womans, the common hyperpigmentation patches which commonly found on face especially on sunlight exposured area. One of the factors causing melasma is the use of oral contraceptives which cause the buildup of the hormones estrogen and progesterone on the skin.Objectives : Thus, the aim of the study is to analyze the association between duration of contraceptive pills use and melasma.Methods : This study used a cross-sectional design. The research was conducted in May-July 2020. The subjects were 36 womans aged 30-55 years old and oral contraceptive acceptors that qualify inclussion criteria and not eligible exclussion criteria. The data was collected primarily using questionnaires. Physical examinations were done through observation with a photo of the respondents. Data analysis using the Chi Square test with a significance value p <0,05.Results : Based on the results of this study, the significance of 0.017 less than 0.05 which indicates a relationship between variables duration of contraceptive pills use and melasma. Conclusions : This study shows a association between duration of contraceptive pills use and melasmaKeywords : melasma, contraceptive pills.

Background: Irritant Contact Dermatitis (ICD) is an eruption of the skin caused by the non-immunologic inflammatory response of the skin to the irritant agents. The government urged to implement health protocols 3M, one of them is hand hygiene by used hand sanitizer to prevent the spread of COVID-19 infection. Repeated use of hand sanitizer can cause skin irritation and inflammatory response such as dryness, cracks, and other symptoms of ICD.Objective: To analyze the relationship between the frequency of use of hand sanitizer and the incidence of ICD.Methods: Observational analytics study cross-sectional design. The research subject were 260 medical faculty students of Diponegoro University who had to agree with informed consent, filled questionnaires and qualified by research criteria. Diagnostic of ICD based on questionnaires and physical examination of ICD. The statistical analysis data was used Chi-square test.Results: The results showed after analyze data use Chi-square test that there was not significantly related frequency use the hand sanitizer to the incidence irritant contact dermatitis during the COVID-19 pandemic with a p-value is 0,078 (p>0,05). The most frequent use of hand sanitizers is 5-10 times a day (56,5%), the most symptoms in ICD are dry, scaly, and peeling skin (30%), and the incidence of ICD due to the use of hand sanitizers are 33,5%.Conclusion: There was no significant relationship between frequency of use of hand sanitizer and irritant contact dermatitis during pandemic the COVID-19.